Wayne Kuznar

Authored Items
Early Detection of Cancer Feasible with Blood-Based Tests
Wayne Kuznar
TOP - July 2020, Vol 13, No 4 in Value-Based Care
Surgery Is a Viable Treatment Option for Patients with Early-Stage Germ Cell Tumors
Wayne Kuznar
TOP - July 2020, Vol 13, No 4 in Survivorship
Universal CAR T-Cells a Promising Off-the-Shelf Therapy for T-Cell Acute Lymphoblastic Leukemia
Wayne Kuznar
TOP - July 2020, Vol 13, No 4 in Leukemia, Value-Based Care
Androgen-Deprivation Therapy Seldom Used with Radiation in Localized Prostate Cancer
Wayne Kuznar
TOP - July 2020, Vol 13, No 4 in Prostate Cancer
Bispecific CAR T-Cells Show Promise in Children and Young Adults with Relapsed B-Cell Acute Lymphoblastic Leukemia
Wayne Kuznar
TOP - July 2020, Vol 13, No 4 in AACR Highlights
De-escalating Chemotherapy Possible in Low-Risk Patients with Advanced Testicular Cancer
Wayne Kuznar
TOP - May 2020, Vol 13, No 3 in ASCO
Gemcitabine-Cisplatin Combination a New Standard in Pancreatic Cancer with Germline BRCA or PALB2 Mutation
Wayne Kuznar
TOP - May 2020, Vol 13, No 3 in ASCO, Pancreatic Cancer
Encorafenib plus Cetuximab Improves Quality of Life versus Standard of Care in Colorectal Cancer Associated with BRAF Mutation
Wayne Kuznar
TOP - May 2020, Vol 13, No 3 in Colorectal Cancer
Promising 3-Drug Regimen for Advanced Gastric Cancer, Regardless of PD-L1 Expression
Wayne Kuznar
TOP - May 2020, Vol 13, No 3 in Immunotherapy
A Call to Focus on Financial Toxicity and Quality of Life in Genitourinary Malignancies
Wayne Kuznar
TOP - May 2020, Vol 13, No 3 in Genitourinary Cancers
Pemigatinib Effective in Patients with Cholangiocarcinoma and FGFR2 Fusion or Rearrangement
Wayne Kuznar
TOP - January 2020, Vol 13, No 1 in Cholangiocarcinoma
Practice-Changing Results: Ivosidenib First Targeted Therapy to Show Benefits in Patients with Cholangiocarcinoma and IDH1 Mutation
Wayne Kuznar
TOP - January 2020, Vol 13, No 1 in Cholangiocarcinoma
What Is the Role of Chemoimmunotherapy in the First-Line Treatment of CLL?
Wayne Kuznar
TOP - January 2020, Vol 13, No 1 in Hematologic Cancers
First-in-Class Sotatercept Improves Hemoglobin Levels in Anemic Patients with Myelofibrosis
Wayne Kuznar
Web Exclusives in Emerging Therapies
Opioid Prescriptions for Pain Management: Safe Patient, Prescriber, Community
Wayne Kuznar
TOP - August 2016, Vol 9, No 3 in Conference Correspondent
Mandatory Oncology Clinical Pathways Can Enhance Value
Wayne Kuznar
TOP - May 2013, Vol 6, No 2 in Best Practices
Helping Patients Overcome Obstacles to Oral Chemo Is Part of Anticancer Drug Management
Wayne Kuznar
TOP - May 2013, Vol 6, No 2 in Best Practices
Preventing Methotrexate Toxicity: Know How to Use Leucovorin, Glucarpidase
Wayne Kuznar
TOP - May 2013, Vol 6, No 2 in Supportive Care
Gene Analysis Allows for Personalization of 5-FU to Reduce Risk of Toxicity
Wayne Kuznar
TOP - May 2013, Vol 6, No 2
Regorafenib Benefit in Colorectal Cancer Not Dependent on Mutations
Wayne Kuznar
TOP - May 2013, Vol 6, No 2 in Colorectal Cancer
Expanding Patient Access to Compassionate-Use Drugs: Pharmacists Can Play a Crucial Role
Wayne Kuznar
TOP - May 2013, Vol 6, No 2 in Best Practices
The 2013 TOP Pharmacist Award Winner
Wayne Kuznar
TOP - May 2013, Vol 6, No 2
Fentanyl Nasal Spray Beats Oral Opioid for Control of Breakthrough Cancer Pain
Wayne Kuznar
Online First
Risk factors for chemotherapy toxicity in elderly are identified
Wayne Kuznar
Online First
Bevacizumab Lengthens Progression-free Survival in Advanced Ovarian Cancer
Wayne Kuznar
Online First
Denosumab Prevents More Skeletal Events than Zoledronic Acid in Men with Prostate Cancer and Bone Metastases
Wayne Kuznar
Online First
Naproxen Reduces Bone Pain After Pegfilgrastim Injection
Wayne Kuznar
Online First
Last modified: December 11, 2015